MultiCell Technologies Inc (MCET)

[zino]

MCET Patent Claims RNA/MSRNA Technology:

>>> US8809290B2 Patent

>>> Method where T cell response enhanced by co-stimulation with one of the following selected from the
group consisting of anti-CD40mAb, recombinant IL-12 or synthetic dsRNA

>>> Method wherein the Ig-G peptide complex and dsRNA are administered repeatedly as an anti-tumor therapy.

>>> Method where upon administration of IgG-peptide and dsRNA, Tc2 immunity is developed against the tumor associated epitope.

>>> Double stranded RNA having a molecular weight from 10 to 50 Kd; wherein the Double-Stranded RNA is pA:pU
and wherein said polypeptide and said Double-Stranded RNA are administered in an amount sufficient to generate
a Tc1 response in the patient to the antigen

>>> The method of claim wherein the polypeptide and Double-Stranded RNA are administered separately.
https://patents.google.com/patent/US8809290B2/en

>>> What is MRNA ? How Pfizer and Moderna tapped new tech to make coronavirus vaccines
https://www.nbcnews.com/science/science-news/what-mrna-how-pfizer-moderna-tapped-new-tech-make-coronavirus-n1248054